GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Apotea AB (publ) APOTEA.ST · SEK

Consumer Staples · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

105.60

+1.25%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 7.20bn

FY2021FY2025

Net income

SEK 228.7m

FY2021FY2025

Free cash flow

SEK 117.7m

FY2021FY2025

Shareholders' equity

SEK 844.0m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 7.20bnSEK 6.54bnSEK 5.45bnSEK 4.88bnSEK 4.56bn
Gross profitSEK 1.94bnSEK 1.79bnSEK 1.45bnSEK 1.27bnSEK 750.3m
Research and development————SEK 597,629
Operating incomeSEK 303.7mSEK 262.8mSEK 112.7mSEK 49.0mSEK 133.6m
Net incomeSEK 228.7mSEK 214.9mSEK 87.0mSEK 19.9mSEK 104.5m
Diluted earnings per share2.202.0842.680.191.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsSEK 1.98bnSEK 146.5mSEK 132.2mSEK 1.25bnSEK 1.02bn
Cash and short-term investmentsSEK 3.3mSEK 2.5mSEK 1.9mSEK 18.2mSEK 81.4m
Total liabilitiesSEK 1.12bnSEK 89.3mSEK 90.1mSEK 897.5mSEK 685.0m
DebtSEK 331.0mSEK 21.8mSEK 25.9mSEK 332.7mSEK 144.3m
Shareholders' equitySEK 844.0mSEK 55.4mSEK 39.9mSEK 327.5mSEK 339.8m
Shares outstanding104m103m2m104m104m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operationsSEK 333.3mSEK 206.2mSEK 215.8mSEK 31.5mSEK 227.3m
Capital spending−SEK 215.6m−SEK 163.8m−SEK 121.1m−SEK 142.1m−SEK 81.5m
Free cash flowSEK 117.7mSEK 42.4mSEK 94.7m−SEK 110.6mSEK 145.8m
Dividends paid———−SEK 28.5m−SEK 28.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 2.03bnSEK 1.94bnSEK 1.85bnSEK 1.77bnSEK 1.83bnSEK 1.75bnSEK 1.73bnSEK 1.63bn
Gross profitSEK 557.8mSEK 548.9mSEK 459.1mSEK 363.3mSEK 510.8mSEK 484.9mSEK 467.9mSEK 320.6m
Operating incomeSEK 104.4mSEK 101.3mSEK 24.5mSEK 88.2mSEK 93.1mSEK 92.4mSEK 51.9mSEK 76.5m
Net incomeSEK 81.4mSEK 79.2mSEK 15.4mSEK 69.6mSEK 72.1mSEK 71.6mSEK 49.4mSEK 56.2m
Diluted earnings per share0.780.760.150.670.690.690.480.55
Cash from operationsSEK 76.0mSEK 112.0m−SEK 64.0mSEK 109.0mSEK 165.0mSEK 123.0mSEK 28.0mSEK 55.0m
Capital spending−SEK 2.0m−SEK 1.0m−SEK 9.0m−SEK 67.0m−SEK 20.0m−SEK 116.0m−SEK 71.0m−SEK 6.0m
Free cash flowSEK 74.0mSEK 111.0m−SEK 73.0mSEK 42.0mSEK 145.0mSEK 7.0m−SEK 43.0mSEK 49.0m
Total assetsSEK 2.23bnSEK 2.22bnSEK 1.98bnSEK 2.26bnSEK 1.98bnSEK 192.0mSEK 146.5mSEK 1.50bn
Cash and short-term investmentsSEK 103.5mSEK 11.1mSEK 3.3mSEK 97.7mSEK 69.2mSEK 2.1mSEK 2.5mSEK 12.1m
DebtSEK 61.7mSEK 61.3mSEK 8.9mSEK 59.3mSEK 66.9mSEK 15.2mSEK 11.8mSEK 62.0m
Shareholders' equitySEK 947.0mSEK 924.6mSEK 91.3mSEK 827.7mSEK 758.2mSEK 68.6mSEK 55.4mSEK 561.8m

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin26.9%27.3%26.6%26.0%16.4%
Operating margin4.2%4.1%2.1%0.7%2.9%
Net margin3.2%3.3%1.6%0.4%2.3%
Return on equity27.1%388.1%217.9%6.1%30.8%
Return on assets11.5%146.7%65.8%1.6%10.2%
Free cash flow yield6.1%4.1%191.1%——
Revenue growth10.1%20.0%11.6%7.0%—
Earnings growth6.4%147.0%337.2%-81.0%—
Current ratio1.28x1.16x1.03x1.01x1.27x
Debt to equity0.10x0.21x0.28x0.47x0.06x
Equity ratio42.6%37.8%30.2%26.1%33.2%
Interest coverage25.15x50.94x24.63x9.16x—
R&D as a share of sales————0.0%
Buybacks as a share of market value-0.9%-4958.5%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.8%——
Operating income83.7%——
Net income125.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.1%26.8%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings42.040.3
Price to sales1.31.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.